“oncomed-pharmaceuticals” Archives

in
Entry Author Date Location
Bio Roundup: Goodbye Belviq, LogicBio on Hold, Revolution’s IPO & More 02/14/20 National
Ligand Inks Deal, Ionis Details Succession Plan, & More SD Biotech 12/21/18 San Diego
Bio Roundup: ASH Wrap, CRISPR Baby Fallout, Moderna’s Record IPO 12/07/18 National
OncoMed’s Saga Ends in Reverse Merger with UK-Based Mereo BioPharma 12/05/18 San Francisco
OncoMed Slashes Workforce After Two Clinical Trial Failures in Cancer 04/24/17 San Francisco
Bio Roundup: Spinraza Woes, Science March, Baseline Launch & More 04/21/17 National
Bio Roundup: CRISPR Appeal, Bristol Deals, Stock Pumping & More 04/14/17 National
OncoMed Shares Sink as One Drug Fails, Bayer Kicks Back Two Others 04/10/17 San Francisco
Led by Former Lilly Exec, Apexian Out to Tackle Pancreatic Cancer 11/16/16 Indiana
West Coast Biotech Roundup: Gilead, Adicet, Otonomy, Fate & More 01/29/16 San Diego
OncoMed Shares Fall After Discouraging News on Pancreatic Cancer Drug 01/25/16 San Francisco
Members Push Merger of 2 California Life Sciences Industry Groups 12/09/14 San Diego
West Coast Biotech Roundup: Burrill, Topol, Aduro, Receptos, & More 06/19/14 San Francisco
Post-IPO Biotechs Have News, But Big Pharma Drives the ASCO Boat 06/06/14 Boston
Lightstone Closes $172M Fund for Early-Stage Biotechs 05/01/14 Boston
At Two-Year Mark, JOBS Act Is Regulation Even A Biotech Can Love 05/01/14 San Francisco
East Coast Biotech Roundup: Juno, Editas, Celgene, & More 12/06/13 Boston
Building Biotechs to Last: See the Agenda for Monday 12/05/13 San Francisco
Celgene Plunks Down $177M Upfront for OncoMed’s Stem Cell Drugs 12/03/13 San Francisco
3 Life Sciences Companies That Are Built to Last 12/02/13 National
Building Biotechs to Last: A Sneak Peek at the Agenda for Dec. 9 11/19/13 San Francisco
Lessons from the St. Louis Cardinals and ‘Building Biotechs to Last’ 10/30/13 San Francisco
Paul Hastings, Adelene Perkins Join Xconomy Biotech Event Dec. 9 10/25/13 San Francisco
The Biotech IPO Phenomenon of 2013: Enjoy It While It Lasts 07/22/13 National
OncoMed Pharmaceuticals Soars in IPO Debut 07/18/13 San Francisco
OncoMed Pharmaceuticals Secures $81,600,000 New Funding 07/18/13 San Francisco
Genomic Health, OncoMed Team Up on Personalized Cancer Drug Work 05/02/12 San Francisco
Verastem, the 15-Month Old Christoph Westphal Venture in Cancer Stem Cells, Seeks IPO 11/03/11 Boston
Stemline Makes Headway Against Cancer Stem Cells And Proves Value of Virtual Model 06/08/11 New York
Onyx Takes a Swing at Myeloma, PacBio Hits Haitian Cholera Genome, Sequenta Nabs $13M, & More Bay Area Life Sciences News 12/10/10 San Francisco
Page 1 of 2 next page »